Loading institutional data...
Loading institutional data...
Institutional ownership roughly stable: -0.33% change quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-05 · 16d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $217.8M 100.0% | $1.47B 100.0% | $1.50B 100.0% | $1.26B 100.0% | $1.69B 100.0% | $1.29B 100.0% | $1.15B 100.0% | $617.2M 100.0% | $259.3M 100.0% |
| Cost of Revenue | $113.8M 52.2% | $567.6M 38.7% | $544.3M 36.3% | $393.3M 31.3% | $327.9M 19.4% | $212.2M 16.4% | $198.6M 17.2% | $91.6M 14.8% | $44.8M 17.3% |
| Gross Profit | $104.1M 47.8% | $899.1M 61.3% | $953.7M 63.7% | $864.6M 68.7% | $1.36B 80.6% | $1.08B 83.6% | $953.0M 82.8% | $525.7M 85.2% | $214.5M 82.7% |
| Research & Development | $19.6M 9.0% | $165.0M 11.3% | $203.5M 13.6% | $235.1M 18.7% | $286.6M 16.9% | $229.2M 17.7% | $177.3M 15.4% | $94.7M 15.3% | $32.6M 12.6% |
| Selling, General & Admin | — | $44.4M 3.0% | $290.8M 19.4% | $260.2M 20.7% | $252.2M 14.9% | $184.0M 14.2% | $160.5M 13.9% | $75.4M 12.2% | $29.7M 11.5% |
| Total Operating Expenses | $145.0M 66.6% | $1.52B 103.9% | $1.01B 67.7% | $967.4M 76.9% | $1.40B 82.6% | $1.14B 88.0% | $807.8M 70.1% | $476.5M 77.2% | $189.7M 73.2% |
| Operating Income | -$40.9M -18.8% | -$624.5M -42.6% | -$61.0M -4.1% | -$102.8M -8.2% | -$32.6M -1.9% | -$56.7M -4.4% | $145.2M 12.6% | $49.1M 8.0% | $24.8M 9.5% |
| Interest & Investment Income | $3.4M 1.5% | $46.5M 3.2% | $48.8M 3.3% | $28.9M 2.3% | $19.3M 1.1% | $39.7M 3.1% | $45.0M 3.9% | $10.9M 1.8% | $176K 0.1% |
| Other Income (Expense), net | $1.8M 0.8% | $1.1M 0.1% | $21.9M 1.5% | $8.2M 0.7% | $12.0M 0.7% | $8.9M 0.7% | $34.8M 3.0% | $990K 0.2% | -$12.2M -4.7% |
| Pretax Income | -$35.2M -16.2% | -$588.1M -40.1% | $7.9M 0.5% | -$87.1M -6.9% | -$16.4M -1.0% | $93K 0.0% | $226.5M 19.7% | $58.3M 9.4% | $13.2M 5.1% |
| Income Tax Expense | $114K 0.1% | -$905K -0.1% | -$18.1M -1.2% | -$21.0M -1.7% | $21.2M 1.3% | -$4.8M -0.4% | $49.7M 4.3% | $3.2M 0.5% | -$4.0M -1.5% |
| Net Income | -$34.6M -15.9% | -$589.5M -40.2% | $21.3M 1.4% | -$65.6M -5.2% | -$8.4M -0.5% | $5.8M 0.4% | $176.7M 15.3% | $55.1M 8.9% | $17.2M 6.6% |
| Per Share | |||||||||
| Weighted Avg Shares (Basic) | 77.9M | 79.4M | 77.6M | 82.7M | 81.7M | 81.5M | 59.4M | 24.6M | 26.9M |
| Weighted Avg Shares (Diluted) | 77.9M | 79.4M | 78.1M | 82.7M | 81.7M | 83.8M | 63.3M | 24.6M | 26.9M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
Free-cash-flow coverage unavailable. Last year: $3M dividends + $2M buybacks = $5M returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 9 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -15%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 9 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-08-05
No standout strengths flagged.
Where each multiple sits in its own 7-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 7-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 14.8 | 17.2 | 16.4 | 19.4 | 31.3 | 36.3 | 38.7 | 52.2 |
| Gross Profit | 85.2 | 82.8 | 83.6 | 80.6 | 68.7 | 63.7 | 61.3 | 47.8 |
| R&D | 15.3 | 15.4 | 17.7 | 16.9 | 18.7 | 13.6 | 11.3 | 9.0 |
| SG&A | 12.2 | 13.9 | 14.2 | 14.9 | 20.7 | 19.4 | 3.0 | — |
| Operating Income | 8.0 | 12.6 | -4.4 | -1.9 | -8.2 | -4.1 | -42.6 | -18.8 |
| Income Tax | 0.5 | 4.3 | -0.4 | 1.3 | -1.7 | -1.2 | -0.1 | 0.1 |
| Net Income | 8.9 | 15.3 | 0.4 | -0.5 | -5.2 | 1.4 | -40.2 | -15.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SY: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash of $60M fully covers short-term debt of $6M.
Mostly short-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Ranked against 1111 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | $1.05T | 51.0× | — | 16.1× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $679.0B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $620.1B | 23.4× | — | 6.6× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $435.4B | 104.3× | 31.4× | 7.1× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| UNH | $374.0B | 31.2× | 21.4× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| BDRX | $359.1B | — | — | — | — | — | — | — | — | — | 7 |
| MRK | $321.1B | 17.6× | — | 4.9× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| NVSEF | $289.9B | — | — | — | — | — | — | — | — | — | 2 |
| AZN | $250.4B | — | — | — | — | — | — | — | — | — | 1,248 |
| AMGN | $219.7B | 28.7× | 18.3× | 6.0× | 10.0% | 67.2% | 21.0% | 89.1% | 13.1% | 3.5× | 3,014 |
| TMO | $217.8B | 32.6× | 28.5× | 4.9× | 3.9% | — | 15.1% | 12.6% | 7.0% | 4.9× | 2,481 |
| ABT | $183.9B | 28.4× | 19.5× | 4.2× | 5.7% | 56.4% | 14.7% | 12.5% | 10.5% | 1.0× | 2,964 |
| GILD | $163.5B | 19.4× | 18.1× | 5.5× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| PFE | $146.7B | 19.0× | — | 2.3× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $141.1B | 39.5× | 29.3× | 5.7× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $133.2B | 47.7× | 36.6× | 13.2× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| SYK | $128.8B | 40.1× | 21.8× | 5.1× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| CVS | $126.0B | 71.3× | 12.7× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| VRTX | $123.1B | 31.6× | 26.9× | 10.3× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| MDT | $110.1B | 23.1× | 11.7× | 3.0× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| GLAXF | $106.9B | — | — | — | — | — | — | — | — | — | 5 |
| MCK | $102.7B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| SNYNF | $101.3B | — | — | — | — | — | — | — | — | — | 5 |
| HCA | $92.0B | 14.5× | — | 1.2× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $86.4B | 15.5× | 14.8× | 0.4× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| SY | $210M | — | — | 1.0× | -85.1% | 47.8% | -15.9% | -15.6% | -15.2% | -0.2× | 31 |
Peers = companies sharing SY's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 32 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position